Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Assessment of Cost-effectiveness and Side-effects of Depressive Patients Treated With ECT or TCA

NCT05306184 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT05306184
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05306184 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Assessment of Cost-effectiveness and Side-effects of Depressive Patients Treated With ECT or TCA
Lead sponsor
Radboud University Medical Center
Phase
Observational
Overall status
Active, not recruiting
Start date
January 1, 2022
Completion date
December 31, 2026
Enrollment
220 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

depressive disorder, major